DORB >> looking good despite the efficacy vote.. READ!!!
Maya Hussain now saying that she would consider, in light of survival advantages of orbec, despite not meeting primary endpoints, advancing or bringing forward discussions of orbec with the FDA.
That is a very good indication, especially coming from Dr. Hussain.
Good luck to all longs. This drug will be approved by the FDA based on everything I heard and saw here today.